Gender Male
Dr. Kennedy earned his medical degree from Vanderbilt Medical School. He completed his internal medicine residency and pulmonary and critical care fellowship at the Johns Hopkins Hospital, and his occupational medicine residency and Masters in Public Health at the Johns Hopkins Bloomberg School of Hygiene and Public Health. He is board certified in
Internal Medicine, Critical Care and Pulmonary Diseases. He is a member of the American Thoracic Society and American College of Chest Physicians.
Dr. Kennedy is a Research Professor of Medicine at Wake Forest University Baptist Medical Center. He was on the faculty of the University of Utah at the time of the founding of JSKT. He has held faculty appointments at the University of North Carolina, Duke, and Tulane University. Dr. Kennedy is a serial entrepreneur. His basic research interest centers on the anti-inflammatory pharmacology of sulfated polysaccharides. Dr. Kennedy has invented the non-anticoagulant heparin CX-01 (ODSH/DSTAT), currently in development for the treatment of acute myeloid leukemia. Dr. Kennedy has developed the combination of thiocarbamates with metals for the treatment of different malignant diseases. Dr. Kennedy also founded GlycoMira, a start-up biotechnology company developing hyaluronic acid derivatives for anti-inflammatory use in skin diseases.
